Beyond phosphorylation: nuclear export in vascular remodeling

Editorial

Jane E B Reusch. Arterioscler Thromb Vasc Biol. 2011 Sep.

. 2011 Sep;31(9):1955-6.

doi: 10.1161/ATVBAHA.111.232645.

No abstract available

Figures

Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway.
Chen WJ, Chen YH, Lin KH, Ting CH, Yeh YH. Chen WJ, et al. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2106-13. doi: 10.1161/ATVBAHA.111.230987. Epub 2011 Jun 16. Arterioscler Thromb Vasc Biol. 2011. PMID: 21680899

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362:801–809. - PubMed
1. Levin YD, White RJ. Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil. Drugs Today (Barc) Feb;47(2):145–156. - PubMed
1. Hewer RC, Sala-Newby GB, Wu YJ, Newby AC, Bond M. PKA and Epac synergistically inhibit smooth muscle cell proliferation. Journal of molecular and cellular cardiology. 2011 Jan;50:87–98. - PMC - PubMed
1. Roscioni SS, Dekkers BG, Prins AG, Menzen MH, Meurs H, Schmidt M, Maarsingh H. cAMP inhibits modulation of airway smooth muscle phenotype via the exchange protein activated by cAMP (Epac) and protein kinase A. British journal of pharmacology. 2011 Jan;162:193–209. - PMC - PubMed
1. Garat CV, Fankell D, Erickson PF, Reusch JE, Bauer NN, McMurtry IF, Klemm DJ. Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells. Mol Cell Biol. 2006 Jul;26:4934–4948. - PMC - PubMed